Micro-RNA Expression Patterns Predict Metastatic Spread in Solid Pseudopapillary Neoplasms of the Pancreas

Area of Science:

• Oncology
• Genomics
• Pancreatic Cancer Research

Background:

• Solid pseudopapillary neoplasm (SPN) of the pancreas is rare with low metastatic potential.
• Predicting malignant behavior in SPN is challenging due to rarity and excellent prognosis.
• Identifying prognostic factors for SPN metastasis is crucial for patient management.

Purpose of the Study:

• To identify clinical, histological, and microRNA patterns associated with metastatic SPN.
• To determine reliable prognostic factors for predicting SPN malignant behavior.
• To explore microRNA expression differences between localized and metastatic SPN.

Main Methods:

• Retrospective analysis of 35 patients operated for SPN (1995-2018).
• Collection of clinical and pathological data, including tumor size and KI67.
• MicroRNA expression profiling of 2,578 microRNAs in normal, localized, and metastatic tissues using microarray and RT-PCR.

Main Results:

• Tumor size was the only clinical factor associated with metastasis (p < 0.012).
• Histological features and KI67 were not predictive of metastasis.
• Differential expression of six microRNAs (miR-184, miR-10a, miR-887, miR-375, miR-217, miR-200c) identified between metastatic and localized SPN.

Conclusions:

• Tumor size is a significant clinical predictor of metastasis in SPN.
• Histological features are unreliable for predicting SPN metastasis.
• A panel of six microRNAs shows potential for predicting SPN tumor behavior, requiring further validation.